The Evolution of Cancer Therapeutics: From Conventional Methods to Targeted and Personalized Approaches

Cancer remains a leading cause of morbidity and mortality worldwide, with an ever-increasing demand for more effective and targeted therapies. The treatment of cancer has evolved dramatically over the past century, from the introduction of surgery and radiation therapy to the emergence of chemotherapy and, more recently, targeted therapies and immunotherapies. These advancements have significantly improved patient outcomes, though challenges such as drug resistance, treatment toxicity, and high treatment costs persist. This review provides a comprehensive overview of the historical, current, and future status of cancer therapeutics. The paper explores the evolution of cancer treatment from traditional methods to the development of novel therapies like immune checkpoint inhibitors, CAR-T cell therapies, and personalized medicine strategies. Furthermore, it discusses the obstacles that remain in the field, such as immune evasion, resistance mechanisms, and the need for more accessible treatment options. Future perspectives highlight the integration of advanced technologies such as liquid biopsy and nanomedicine, which promise to revolutionize cancer treatment by enabling early detection, improved targeting, and reduced side effects. The ongoing advancements in cancer therapeutics hold great promise for improving survival rates and quality of life for cancer patients, with the hope of achieving more effective, less toxic, and universally accessible therapies.